Epstein Files Search

EFTA01110707Set 9

22p7,189w

Neurosurgery JEFFERSON MEDICAL COLLEGE, Philadelphia, PA, USA EFTA01110707 LEONE, Paola 1998-2001 Associate Director CNS Gene Therapy Center JEFFERSON MEDICAL COLLEGE, Philadelphia, PA, USA 2002-2007 Associate Professor Department ... Japan 2004 Myelin Project Annual Meeting, Aquiterme, Italy 2004 NAA Symposium, Bethesda, MD 2004 CNS Foundation, Tarrytown, NY 2005 National Tay Sachs & Allied Disorders, Annual Conference,New Orleans 2005 American ... Leone, P., Janson, C.G., McPhee, S.J., During, M.J. (1999) Global CNS Gene Transfer for Childhood Neurogenetic Enzyme Deficiency: Canavan Disease. Current Opinions in Molecular Therapeutics

https://www.justice.gov/epstein/files/DataSet%209/EFTA01110707.pdf

EFTA01079016Set 9

2015-12-3169p22,497w

December 2015 I 2013 multiples include the following firms: APAM, BPFH, CLMS, CNS, DHIL, EV, GBONS, PZN, SAMG, VRTS, WDR and WHG. 2014 multiples include the following firms: APAM, BPFH ... CLMS, CNS, DHIL, EV, GBL, JNS, PZN, SAMG, VRTS, WDR and WHG. 2015 multiples include APAM, BPFH, CLMS, CNS, OHIL, EV, GSL, INS, PZN, SAMG, VRTS, WDR and WHG. Berkshire ... rates. Index includes AMG, APAM (as of 3/13), ART (3/11through 12/12), BEN, BLK, CLMS, CNS, EPHC (3/11 through 11/12), EV, FII, GBL, GROW (3/11through 4/12

https://www.justice.gov/epstein/files/DataSet%209/EFTA01079016.pdf

EFTA00799222Set 9

73p4,210w

treatment options in drug discovery and development • We have privileged access to global CNS pharma experts through our Scientific Advisory Board • Provide advice, share knowledge and offer insights on different ... Correlate of Cognitive Decline Clinical Disease Stage Sperling et al., 2011 EFTA00799243 How are CNS Synapses Eliminated ? oiigodenerocyte Neuron EFTA00799244 Immune System: Complement Proteins are 'Eat me' signals that ... EFTA00799248 Development/Plasticity/Repair J J Neuroscience (2013) A Dramatic Increase of Clq Protein in the CNS during Normal Aging Alexander H. Stephan,' Daniel V. Madison,2 Jose Maria Mateos,3 Deborah

https://www.justice.gov/epstein/files/DataSet%209/EFTA00799222.pdf

EFTA00903627Set 9

2011-02-063p1,232w

also causes a wide range of structural and functional defects. The central nervous system (CNS) is most at risk probably because it cannot compensate for the loss of prospective neurons ... predicted by the thalidomide cases in both time of origin and central nervous system (CNS) location. To produce similar brain lesions experimentally, the team exposed rat embryos to valproic acid ... external malformations. The autopsy data and experimental data from rats confirm that CNS injuries occurring during (or just after neural tube closure) can lead to a selective loss of neurons

https://www.justice.gov/epstein/files/DataSet%209/EFTA00903627.pdf

EFTA01714588Set 10

2005-02-2458p18,026w

NA44 WS 0.00 186 02/27 08:50PM HI N PALM FL 5 NA44 CNS 0.00 167 02/27 09:05PM HI INCOMI CL 1 NA44 INS 0.00 188 02/27 09:08PM ... NA44 0 WS 0.00 296 03/03 10:10PM NI PALM FL 13 NA44 0 CNS 0.00 297 03/03 10:22PM NI INCOMI CL 12 NA44 0 IONS 0.00 298 02/03

https://www.justice.gov/epstein/files/DataSet%2010/EFTA01714588.pdf

EFTA00296820Set 9

17p6,870w

NICU) B. Autonomic-neurophysiologic (e.g., number of hypotensive episodes) C. Medical (e.g., exposure to CNS-active drugs) D. Behavioral (e.g., exploratory motor behaviors) EFTA00296826 Tramo GRANT PROPOSAL: The Jeffrey Epstein ... mechanical ventilation and tube feedings, sleep-wake cycles, exposure to sedatives and other CNS-active drugs, and weight gain — will be monitored daily. Salivary cortisol and IgA will be analyzed ... from the NICU, and collection of data about medical complications, exposure to drugs with CNS activity, weight gain, length of acute-care hospital stay, and total acute-care costs will

https://www.justice.gov/epstein/files/DataSet%209/EFTA00296820.pdf

EFTA01127977Set 9

2014-09-249p2,510w

enormous success in the identification of novel therapeuti c targets for a variety of CNS disorders—including Parkinson's disease, schizophrenia, and age-related cognitive decline —which have already ... been employed by the Greengard and Heintz laboratories for comparative analysis of nearly 100 CNS cell types, including many of those that comprise the CSTC circuitry relevant to OCD. These ... studies have resulted in identification of novel therapeutic targets for a variety of CNS disorders—including Parkinson's disease, schizophrenia, and age-related cognitive decline—that have already

https://www.justice.gov/epstein/files/DataSet%209/EFTA01127977.pdf

EFTA01178505Set 9

4p2,741w

case of tetanus, utilize retro- Relevant human data grade signaling to the CNS. Given the well charac- There are no published clinical trials or even case terized pathogenicity of these ... tetanus toxin, can be dietary fiber intake, and decreased physical activity transported to the CNS despite an intact blood- (22). However, a study using radio-opaque markers brain barrier ... controls even if they did not complain of in a retrograde fashion to the CNS, and thus has GI symptoms; this abnormal colonic motility did not been studied

https://www.justice.gov/epstein/files/DataSet%209/EFTA01178505.pdf

EFTA00903625Set 9

2011-02-062p1,064w

also causes a wide range of structural and functional defects. The central nervous system (CNS) is most at risk probably because it cannot compensate for the loss of prospective neurons ... predicted by the thalidomide cases in both time of origin and central nervous system (CNS) location. To produce similar brain lesions experimentally, the team exposed rat embryos to valproic acid ... external malformations. The autopsy data and experimental data from rats confirm that CNS injuries occurring during (or just after neural tube closure) can lead to a selective loss of neurons

https://www.justice.gov/epstein/files/DataSet%209/EFTA00903625.pdf

EFTA00707641Set 9

2017-09-1024p6,911w

cranial and/or spinal nerves,and transporting the therapeutic peripherally through the nerves into the CNS. Publication number WO 2005021065 A3 Year 2005 Title Use of particulate agents Abstract A novel ... intranasal route. Neurological diseases and conditions are associated with reduced brain insulin signaling (i.e., CNS insulin insensitivity), reduced dopaminergic signaling, reduced serotonergic signaling, reduced cholinergic signaling, or reduced GABAergic signaling ... insomnia, or EFTA00707659 anxiety. Neurological diseases also include cancers of the central nervous system (CNS). Publication number US 20140100282 Al Year 2014 Title Method and applications of peptide- mediated mitochondrial

https://www.justice.gov/epstein/files/DataSet%209/EFTA00707641.pdf

EFTA02683561Set 11

2014-09-249p2,522w

with enormous success in the identification of novel therapeutic targets for a variety of CNS disorders—including Parkinson's disease, schizophrenia, and age-related cognitive decline —which have already ... been employed by the Greengard and Heintz laboratories for comparative analysis of nearly 100 CNS cell types, including many of those that comprise the CSTC circuitry relevant to OCD. These ... studies have resulted in identification of novel therapeutic targets for a variety of CNS disorders—including Parkinson's disease, schizophrenia, and age-related cognitive decline—that have already

https://www.justice.gov/epstein/files/DataSet%2011/EFTA02683561.pdf

EFTA00671106Set 9

2011-02-063p1,340w

also causes a wide range of structural and functional defects. The central nervous system (CNS) is most at risk probably because it cannot compensate for the loss of prospective neurons ... predicted by the thalidomide cases in both time of origin and central nervous system (CNS) location. To produce similar brain lesions experimentally, the team exposed rat embryos to valproic acid ... external malformations. The autopsy data and experimental data from rats confirm that CNS injuries occurring during (or just after neural tube closure) can lead to a selective loss of neurons

https://www.justice.gov/epstein/files/DataSet%209/EFTA00671106.pdf

EFTA01271382Set 10

2012-05-31203p88,075w

xrnn antic IN Mtn; ne fettle, deldird3 lee ran Mar Fain CNs: (Dan A peon' lee 'as Far« 1. Min NW Otil onnrilgt Pt. luµnatdaes Cannes for re Bing Stot

https://www.justice.gov/epstein/files/DataSet%2010/EFTA01271382.pdf

EFTA01146437Set 9

2012-08-2332p8,298w

Institute for Brain Science 9:30 AM Mapping Gene Expression and Connections in the CNS: Tools and Data from the Allen Institute for Brain Science Allan Jones, PhD, Allen Institute ... Cracking the Neural Code 11 EFTA01146447 ABSTRACTS Mapping Gene Expression and Connections in the CNS: Tools and Data from the Allen Institute for Brain Science Allan Jones, PhD, Allen Institute

https://www.justice.gov/epstein/files/DataSet%209/EFTA01146437.pdf

EFTA00711710Set 9

2017-03-1943p14,125w

doctor visits by people over the age of 65 involved three or more CNS-affecting drugs; the number jumped to 1.4 percent in 2013. If that percentage were applied ... would mean 3.68 million doctor visits a year involving seniors taking three or more CNS drugs, up from about 1.5 million visits in 2004, according to a press release

https://www.justice.gov/epstein/files/DataSet%209/EFTA00711710.pdf

EFTA00666019Set 9

2011-04-233p1,092w

hyperinsulinemia also results in a lower level of leptin signal transduction, conveying a CNS signal of energy insufficiency. The remaining calories available are lower than his energy expenditure; the CNS

https://www.justice.gov/epstein/files/DataSet%209/EFTA00666019.pdf

EFTA01099525Set 9

2014-01-28140p21,399w

Filing Party: Disposition Amount: Docket Text: (SUPPLEMENTAL) OF DEFT EPSTEIN 77 CNS - CONSENT Filing Date: 11-JUN-2010 Filing Party: 'Disposition Amount: http://courtcon.co.palm-beach.fl.us/pls/jiwpfck_publicAry doct.c...port?backto.Plicase_id=502009CA040800XXXXM88/begin_date ... Filing Date: 15-FEB-2011 Filing Party: Disposition Amount: Docket Text: CHRISTINA FITCH 242 CNS - CONSENT Filing Date: 16-FEB-2011 Filing Party: EPSTEIN, JEFFREY Disposition Amount: Docket Text

https://www.justice.gov/epstein/files/DataSet%209/EFTA01099525.pdf

EFTA00593632Set 9

2015-04-0112p7,332w

result investors should be aware that the firm may have a conflict CNS Monitoring fee expired in 4Q, drops to zero in 1Q: this drives a 29% of interest that ... shares near-term. While it's possible none could sell, history suggests partial selling. CNS Monitoring fee expires in 4Q14, drops to zero in 1Q15: We flag as a headline

https://www.justice.gov/epstein/files/DataSet%209/EFTA00593632.pdf

EFTA00284317Set 9

2011-10-196p4,049w

REDI GSCO 0.00 334.50 334.50 0.03 020 USO PerUnd FNE 101192011 10+242011 Buy CNS COHEN & STEERS INC 9.837 26.2505 0.0150 258.373.73 INCE GSCO ... PerUnd FNE 1011912011 10242011 Buy CNS COHEN & STEERS INC 20.663 262970 0.0150 543.684.86 REDT GSCO 0.00 309.95 309.95 0.03 020 USO PerUnd FNE TOTALS

https://www.justice.gov/epstein/files/DataSet%209/EFTA00284317.pdf

EFTA02167989Set 10

2012-05-298p2,736w

Thursday® 12:00pm Coverage: AB (Hold), BEN (Bey). BK (Hold). BLK (Buy). BX (Buy). CNS (Hold), EV (Hold), FIG (Hold). HI (Hold). WI(Buy). JNS (Holt:B. LAI(Hold

https://www.justice.gov/epstein/files/DataSet%2010/EFTA02167989.pdf